N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. - Wikidata - awgldk - TriplyDB

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.

http://www.wikidata.org/entity/Q35133059

about

The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers The role of genetic polymorphisms in environmental health.Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis Structural basis of substrate-binding specificity of human arylamine N-acetyltransferases N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3 A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci Mendelian Randomization for Strengthening Causal Inference in Observational Studies Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?Biochemical and molecular epidemiology of human cancer: indicators of carcinogen exposure, DNA damage, and genetic predisposition.Artificial targeting of misfolded cytosolic proteins to endoplasmic reticulum as a mechanism for clearance.Pharmacogenetic perspectives on susceptibility to toxic industrial chemicals Assessment of risk by biological monitoring.The association of the slow acetylator phenotype with bladder cancer.Hemoglobin adducts of aromatic amines: associations with smoking status and type of tobacco.N-acetyltransferase 2 and bladder cancer: an overview and consideration of the evidence for gene-environment interaction.Pharmacogenetics of the arylamine N-acetyltransferases.Comparative biology of test species.Acetylation, deacetylation and acyltransfer.Arylamine-DNA adducts in vitro and in vivo: their role in bacterial mutagenesis and urinary bladder carcinogenesis.Promotion in urinary bladder carcinogenesis.Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes 4-Aminobiphenyl and DNA reactivity: case study within the context of the 2006 IPCS Human Relevance Framework for Analysis of a cancer mode of action for humans.Commentary: Reflections on G. M. Lower and colleagues' 1979 study associating slow acetylator phenotype with urinary bladder cancer: meta-analysis, historical refinements of the hypothesis, and lessons learned.Familial and genetic risk of transitional cell carcinoma of the urinary tract.N-Acetyltransferase polymorphism and human cancer risk.Update on the pharmacogenetics of NATs: structural considerations.Insights into how protein dynamics affects arylamine N-acetyltransferase catalysis.Toxicogenetic profile and cancer risk in Lebanese.Polymorphisms of xenobiotic metabolizing enzymes in bladder cancer patients of the Semmelweis University Budapest, Hungary.Epidemiology of transitional cell carcinoma of the bladder: profile of an urban population in the south-west of England.Advances in genetics and immunology: the importance of basic research to prevention of occupational diseases.Survey of the human acetylator polymorphism in spontaneous disorders.Effects of butylated hydroxyanisole and butylated hydroxytoluene on DNA adduct formation and arylamine N-acetyltransferase activity in human bladder tumour cells.Effects of aspirin on arylamine N -acetyltransferase activity and DNA adducts in human bladder tumour cells.Liver NADPH-dependent oxidation of the 5-nitrofurans, FANFT and ANFT, by guinea pig and rat.N-Acetyltransferase phenotype of patients with bladder cancer.N-acetyltransferase activity in the urine in Japanese subjects: comparison in healthy persons and bladder cancer patients.Modeling human interindividual variability in metabolism and risk: the example of 4-aminobiphenyl.

P2860

Q23923016-E59A8A82-EB57-4659-92FE-CFFF7BC47564 Q24815139-2203E68B-59F3-4620-BAB3-BDEE3E7DACC5 Q26771643-093DC389-A279-4524-B3B1-2B33903B59DE Q27646887-E9C09C00-9E19-4E12-8A5B-8951F5811EF2 Q28388128-4438DF3B-9F6C-43E3-8AC0-46E09FDFD7C4 Q28943348-9DC3C4A9-5279-4F2D-A7ED-F13ACA5AB2BA Q28943367-B41AB05F-258F-4025-A056-88AF702730B6 Q29037397-1AEAF3A5-F09B-4FBB-8E9A-4FB13C78F1E3 Q30251624-B7740827-AC4B-48B0-A730-98FCA16168E5 Q30499785-98C281F1-2AAC-4D04-B4A4-F09F0B5F52CF Q30657635-11CF6733-C7AF-4E9B-8D35-B59A9AB72A8E Q33572836-A0F9E2E3-E215-403E-8EF1-9C981D7AD9F5 Q33575172-157A5127-43A3-431A-8C2B-B4790DE1A1D8 Q33670806-60CE20E2-6112-4B0D-9F08-2252C1EC5CAE Q33688592-4F765447-CC0D-4830-8E23-EBB58E47063D Q33985340-4CDA12BC-3F0E-4762-8F33-7883A16BABA9 Q34624647-D9E4E512-1267-4373-B116-2CC2E249BD0B Q34660522-60B92BD6-95CD-45C0-B277-4CE78A29DC21 Q35037134-29FF5EAF-5C12-4F74-9292-29C28E61992F Q35037159-72A72CBD-841A-45B3-8E73-C8BA26EFE162 Q35037492-D30FD13B-4D88-4E01-B93A-E1A3D73700A8 Q35644340-71BB9E18-CD72-439A-85AC-2D422C11462A Q36283262-82A2302F-FCCC-44E2-9B2A-BDBB6E8537DF Q36659782-6E1A0D80-A606-4CA6-ABC3-4FF672B80BE3 Q36825511-AF936E48-99C7-4022-9EBC-6D42FBF37DF7 Q36951321-B1C8DF90-D739-43EA-8488-35B3D61D2895 Q37296621-BCAA39D5-C03A-4426-B95A-C80376842715 Q37329162-1CB8665C-6062-474E-BC69-E92521DF45DC Q37357587-20751489-87FB-4E8A-A053-BD8A1CD00C07 Q38195853-289E87D8-2D65-4EB5-9444-37E070F5F826 Q38684214-B0B5C723-EAFB-4AE0-848C-E9B6E6EA814B Q39481292-3839004B-4990-46C4-9A59-65ABFE9D7065 Q40183908-C44160E5-8692-40C0-BD00-BC965A77BFBE Q40190123-FDF8CFDD-309E-4488-84D3-8A427E7DDBF1 Q40755245-6DA26284-C5E0-4124-83AF-C45B83A0DC91 Q40919785-E1EAA538-8D05-4BD9-9CF1-C810A59A24C6 Q42558309-6C43786F-9ABE-492E-AFBD-9266D9BCDCBE Q43988332-7804F3FA-8FAA-4420-B75F-35997DEF5EAA Q44380081-ECA975C9-87B6-4EAF-ACC1-18EF2D9D9C69 Q46979699-3F713BDF-EDA7-430B-A57B-C9B2B6F0A5CE

P2860

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.

http://www.wikidata.org/entity/Q35133059

description

1979 nî lūn-bûn

@nan

1979 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1979 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1979年の論文

@ja

1979年論文

@yue

1979年論文

@zh-hant

1979年論文

@zh-hk

1979年論文

@zh-mo

1979年論文

@zh-tw

1979年论文

@wuu

name

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@ast

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@en

type

label

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@ast

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@en

prefLabel

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@ast

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@en

P1433

Q35133059-5E60D56D-05FF-4EBB-9A26-0E5F106B7F8A

P1476

Q35133059-93553DB0-37FA-45EC-96DF-E1988A2C3E12

P2093

Q35133059-3077C63A-B580-4BCA-87E6-D9D68596C7A4

Q35133059-36668B98-B6FF-4C15-BF4B-9CF0BC1B9087

Q35133059-5B4D7B97-2015-4A15-9768-99F105138512

Q35133059-92445447-712D-4326-AF02-3394A345FFF6

Q35133059-EF4F05D8-D0F2-4F66-9ED5-A0AB973124CF

Q35133059-FC9517E4-16D9-4E0F-AD1C-1D3E99CD1935

P2860

Q35133059-02615E21-694F-445A-B53B-D6C3A5F9BF0F

Q35133059-077D42E3-76D9-4ED8-B784-C84E3EABEB3F

Q35133059-1F56CB79-10B2-4E72-82AF-70AEF46694B0

Q35133059-28235A29-C092-426D-A752-4345D79BA2C2

Q35133059-4B2B30D9-F8EA-4415-9EEA-9D7D3C206EDF

Q35133059-5157A9C4-077D-4F32-BDB0-23A16BB454FE

Q35133059-61B2DB88-C90A-43CC-AF95-BAC74BC70F94

Q35133059-74DE11CB-8A47-4AD2-B1F3-4D80C8B80BA0

Q35133059-984B592E-18A1-4E85-9F86-FD8C2DE787A3

Q35133059-9EB24854-7FF7-477C-A01F-029CD956502F

P304

Q35133059-E3FEA50A-CDA2-4385-AB81-CBB5BF064F44

P31

Q35133059-4CFC1B30-3468-405E-8BC5-21159D05A2A7

P356

Q35133059-0211D674-B434-4840-968B-8488DF3D4800

P478

Q35133059-34191D93-D2DF-47B7-8286-6B0FAAA35EFA

P577

Q35133059-FECF5405-1F60-4701-B4D0-FE7BBA6910DC

P698

Q35133059-29D26BF9-8E18-402F-A438-9DF09A28E601

P921

Q35133059-BA105A58-F46E-4675-A8FA-31F31725B3CD

P932

Q35133059-3C968802-50D5-466A-94A9-F6928205044C

P356

P1433

Environmental Health Perspectives

P1476

N-acetyltransferase phenotype ...... results in Sweden and Denmark.

@en

P2093

Bryan GT

http://www.w3.org/2001/XMLSchema#string

Gamsky TE

http://www.w3.org/2001/XMLSchema#string

Lower GM Jr

http://www.w3.org/2001/XMLSchema#string

Nelson CE

http://www.w3.org/2001/XMLSchema#string

Nilsson T

http://www.w3.org/2001/XMLSchema#string

Wolf H

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis

Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype

Clinical consequences of polymorphic acetylation of basic drugs

Isoniazid-associated hepatitis in 114 patients

A filter paper method for determining isoniazid acetylator phenotype

The role of the pathologist in environmental medicine and public health

Enzymic deacetylation of carcinogenic arylacetamides by tissue microsomes of the dog and other species.

Activation of the O-glucuronide of the carcinogen N-hydroxy-N-2-fluorenylacetamide by enzymatic deacetylation in vitro: formation of fluorenylamine-tRNA adducts.

Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat.

Biochemical formation and pharmacological, toxicological, and pathological properties of hydroxylamines and hydroxamic acids.

P304

71-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1289/EHP.792971

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

1979-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

510245

http://www.w3.org/2001/XMLSchema#string

P921

P932

1637362

http://www.w3.org/2001/XMLSchema#string